The NHS has launched a national COVID Cancer Antibody Survey to assess antibody responses to the COVID-19 vaccines among cancer patients and is calling on cancer patients to sign up now.
You can sign up here: https://covidcancersurvey.uk/
Vaccination is an important strategy to protect society from the effects of COVID-19, but there is emerging evidence that a small number of cancer patients may have lower levels of antibody response than the general population. We don’t yet fully understand what lower levels of antibodies mean in terms of outcomes, but it may mean some people with cancer are not as protected from COVID-19.
The COVID Cancer Antibody Survey is one of the first surveys of its kind that will help us understand what protection people with cancer develop following COVID-19 infection and/or vaccination.